Veeva

Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. Veeva operates as a Public Benefit Corporation.

Latest News

May 30, 2024 Veeva Announces Fiscal 2025 First Quarter Results
Total Revenues of $650.3M, up 24% Year Over Year; Subscription Services Revenues of $534.0M, up 29% Year Over Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2024. "Thanks to our customers and the Veeva team we had an excellent start to the year," said CEO Peter Gassner. "We made major progress in Development Cloud, Commercial Cloud, and Data Cloud." Fiscal 2025 First Quarter Results: Revenues (1) : Total revenues for the first quarter were $650.3 million, up from $526.3 million one year ago, an increase of 24% year over year. Subscription services revenues for the first quarter were $534.0 million, up from $414.5 million one year ago, an increase of 29% year over year. Operating Income and Non-GAAP Operating Income (1)(2) : First quarter operating income was $155.2 million, compared to $61.5 million one year ago, an increase of 152% year over year....
Read More
February 29, 2024 Veeva Announces Fourth Quarter and Fiscal Year 2024 Results
Fiscal Year 2024 Total Revenues of $2,363.7M, up 10% Year Over Year; Q4 Total Revenues of $630.6M, up 12% Year Over Year Fiscal Year 2024 Subscription Services Revenues of $1,901.6M, up 10% Year Over Year; Q4 Subscription Services Revenues of $521.5M, up 13% Year Over Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2024. "The fourth quarter was a strong finish to an important year for Veeva," said CEO Peter Gassner. "Executing on our long-term industry cloud opportunity, we delivered the Veeva Compass Suite of data products, established the Clinical Platform, and progressed our new Commercial Cloud. These advances will fuel our growth and have a major impact on the industry for years to come." Fiscal 2024 Fourth Quarter Results: Revenues : Total revenues for the fourth quarter were $630.6 million, up from $563.4 million one...
Read More